alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>   1

                                  EXHIBIT 23.1


               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

   
         We consent to the reference to our firm under the caption "Experts" in
Amendment No. 2 to the Registration Statement (Form S-3 No. 333-44637) and 
related Prospectus of Ride, Inc. for the registration of 2,608,729 shares of
its common stock and to the incorporation by reference therein of our report
dated March 3, 1998, with respect to the consolidated financial statements and
schedule of Ride, Inc. included in its Annual Report (Form 10-K) for the year
ended December 31, 1997, filed with the Securities and Exchange Commission.






Seattle, Washington
March 24, 1998                             ERNST & YOUNG LLP
<PAGE>   1
                                                                   EXHIBIT 23(a)

                                  [LETTERHEAD]



                                January 22, 1999



Aristar, Inc.
Hidden River Corporate Park
8900 Grand Oak Circle
Tampa, FL 33637-1050


Ladies and Gentlemen:

     
     We hereby consent to the incorporation by reference of this letter as an
exhibit to the Company's Registration Statement on Form S-3 (File No. 333-29049)
(the "Registration Statement"). We consent further to the reference to our firm
under the heading "Legal Opinions" in the Prospectus Supplement dated
January 22, 1999, to the Prospectus dated June 23, 1997, which forms a part of
the Registration Statement.


                                        Very truly yours,

                                        /s/  FOSTER PEPPER & SHEFELMAN PLLC
EXHIBIT 32
----------




                            CERTIFICATIONS OF
           CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                   PURSUANT TO 18 U.S.C. SECTION 1350,
                AS ADOPTED PURSUANT TO SECTION 906 OF THE
                       SARBANES-OXLEY ACT OF 2002
           ---------------------------------------------------



      The following statement is provided by the undersigned to accompany
the Quarterly Report on Form 10-Q for the quarter ended September 30, 2008,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be
deemed filed pursuant to any provision of the Securities Exchange Act of
1934 or any other securities law:

      Each of the undersigned certifies that the foregoing Report on
Form 10-Q fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the information
contained in the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of ALP Liquidating Trust.




                                        /s/   Gary Nickele
                                        ------------------------------
                                        Gary Nickele
                                        Chief Executive Officer




                                        /s/   Gailen J. Hull
                                        ------------------------------
                                        Gailen J. Hull
                                        Chief Financial Officer and
                                        Principal Accounting Officer
§ 520.1197 Ivermectin sustained-release bolus. ( a ) *Specifications.* Each sustained-release bolus contains 1.72 grams of ivermectin.
( b ) *Sponsor.* See No. 000010 in § 510.600(c) of this chapter.
( c ) *Related tolerances. See § 556.344 of this chapter .*
( d ) *Conditions of use in ruminating calves* — ( 1 ) *Amount.* Administer one bolus per calf weighing at least 275 pounds (lb) (125 kilograms (kg)) and not more than 660 lb (300 kg) on the day of administration.
( 2 ) *Indications.* For treatment and control, throughout the grazing season (approximately 130 days), of gastrointestinal roundworms *Haemonchus placei, Ostertagia ostertagi* (including inhibited fourth-stage larvae), *Trichostrongylus axei, T. colubriformis, Cooperia* spp., *Nematodirus helvetianus, Bunostomum phlebotomum, Oesophagostomum radiatum;* lungworms *Dictyocaulus viviparus;* grubs *Hypoderma* spp.; sucking lice *Linognathus vituli, Solenopotes capillatus;* mange mites *Psoroptes ovis, Sarcoptes scabiei,* and ticks *Amblyomma americanum.*
( 3 ) *Limitations.* The bolus was specifically designed for use in cattle; do not use in other animal species. Calves must be ruminating and older than 12 weeks of age. Do not administer to calves weighing less than 275 lb (125 kg). Do not administer a damaged bolus. Because a milk withdrawal time has not been established, do not use in female dairy cattle of breeding age. Do not slaughter cattle within 180 days of treatment. Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
[61 FR 67452, Dec. 23, 1996, as amended at 62 FR 63270, Nov. 28, 1997; 65 FR 45876, July 26, 2000; 84 FR 39183, Aug. 9, 2019]
§ 516.1858 Potassium bromide. ( a ) *Specifications.* Each chewable tablet contains 250 or 500 milligrams (mg) potassium bromide.
( b ) *Sponsor.* See No. 055246 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Amount.* Administer 25 to 68 mg per kilogram (11 to 31 mg per pound) of body weight once daily. The dosage can be divided and should be adjusted to clinical response.
( 2 ) *Indications for use.* For the control of seizures associated with idiopathic epilepsy in dogs.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal law to use this product other than as directed in the labeling.
[86 FR 57996, Oct. 20, 2021]
#### KARPPINEN *v.*TAMARACK MINING CO.1

Master and Servant — Injuries to Servant — Mines — Safe Place to Work.

This case, involving the liability of the owner of a mine for injuries to a trammer caused by a fall of rock from the hanging wall of the mine, is ruled by *Petaja*v. *Mining Go.,*106 Mich. 463, involving similar facts.

Error to Houghton; Streeter, J.

Submitted October 14,1908.

(Docket No. 71.)

Decided November 2, 1908.

Case by Henry Karppinen against the Tamarack Mining Company for personal injuries. There was judgment for defendant on a verdict directed by the court, and plaintiff brings error.

Affirmed.

P. *H. O’Brien,*for appellant.

*Ball & Stone,*for appellee.

1

 Rehearing pending.

*529Hooker, J.

The plaintiff has appealed from an adverse verdict directed by the trial judge. The plaintiff was injured by the fall of rock from the hanging wall of defendant’s mine after working therein as a trammer for thirty days. At the time of the injury he was loading rock which had been broken down, shoveling it upon the tram car,- which stood at the end of the track in close proximity. The case is substantially like that of *Petaja*v. *Mining Co.,*106 Mich. 463, and is clearly within the rule there stated, and does not require a lengthy discussion.

The judgment is affirmed.

Grant, C. J., and Blair, Moore, and McAlvay, JJ., concurred.
§ 522.2615 Tripelennamine. ( a ) *Specifications.* Each milliliter of solution contains 20 milligrams (mg) of tripelennamine hydrochloride.
( b ) *Sponsors.* See Nos. 016592 and 051031 in § 510.600(c) of this chapter.
( c ) *Related tolerances.* See § 556.741 of this chapter.
( d ) *Conditions of use* — ( 1 ) *Dogs and cats* — ( i ) *Amount.* Administer 0.5 mg per pound of body weight by intramuscular injection.
( ii ) *Indications for use.* For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.
( iii ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 2 ) *Horses* — ( i ) *Amount.* Administer 0.5 mg per pound of body weight by intramuscular injection.
( ii ) *Indications for use.* For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.
( iii ) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
( 3 ) *Cattle* — ( i ) *Amount.* Administer 0.5 mg per pound of body weight by intravenous or intramuscular injection.
( ii ) *Indications for use.* For use in treating conditions in which antihistaminic therapy may be expected to lead to alleviation of some signs of disease.
( iii ) *Limitations.* Milk taken during treatment and for 24 hours after the last treatment must not be used for human consumption. Cattle must not be slaughtered for human consumption within 4 days following the last treatment with this drug product. Not for use in beef calves less than 2 months of age, dairy calves, and veal calves. A withdrawal period has not been established for this product in pre-ruminating calves. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[51 FR 44450, Dec. 10, 1986, as amended at 61 FR 29480, June 11, 1996; 62 FR 4164, Jan. 29, 1997; 78 FR 17597, Mar. 22, 2013; 79 FR 16198, Mar. 25, 2014; 81 FR 22524, Apr. 18, 2016; 82 FR 11508, Feb. 24, 2017; 87 FR 58962, Sept. 29, 2022]
### Surface water supply of the United States, 1961-65, Part 12. Pacific slope basins in Washington, Volume 2. Upper Columbia River basin

By: Water Resources Division, U.S. Geological Survey

                            https://doi.org/10.3133/wsp1933

#### Links

-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Plate:  **Plate 1**                            (pdf)
- NGMDB Index Page:  **National Geologic Map Database Index Page**
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

No abstract available.

#### Study Area

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
#### § 515.40 Judicial review.

The transcript and record shall be certified by the Commissioner of Food and Drugs (the Commissioner). In any case in which the Commissioner enters an order without a hearing under § 314.200(g) of this chapter, the request(s) for hearing together with the data and information submitted and the Commissioner's findings and conclusions shall be included in the record certified by the Commissioner.
<PAGE>   1
                                                                      EXHIBIT 16

[David O. Christensen CPA & Consultants LOGO]

February 23, 1998



Securities and Exchange Commission
450-5th St., NW
Washington, DC 20549

Regarding:  Citizens Bancorp 8-K

Dear Sirs:

We have been furnished with a copy of the response to Item 4 of Form 8-K for the
event that occurred on February 17, 1998, to be filed by our former client,
Citizens Bancorp. We agree with the statements made in response to that item
insofar as they relate to our firm.

This letter is attached to the 8-K of Citizens Bancorp.

Sincerely,

/s/ David O. Christensen
------------------------------
David O. Christensen
Certified Public Accountants & Consultants
I 

118TH CONGRESS 

2D SESSION H. R. 7467 

To amend the Head Start Act to permit some teachers in Early Head 

Start programs to teach while earning a child development associate 

credential. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 28, 2024 

Mr. CISCOMANI (for himself and Ms. SHERRILL) introduced the following bill; 

which was referred to the Committee on Education and the Workforce 

A BILL 

To amend the Head Start Act to permit some teachers 

in Early Head Start programs to teach while earning 

a child development associate credential. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Head start Education 

5 And Development Workforce Advancement and Yield Act’’ 

6 or the ‘‘HEADWAY Act’’. 

7 SEC. 2. TEACHERS IN EARLY HEAD START PROGRAMS. 

8 Section 645A(h) of the Head Start Act (42 U.S.C. 

9 9840a(h)) is amended— 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7467 IH

1 (1) in paragraph (1)— 

2 (A) by striking ‘‘, not later than Sep3 tember 30, 2010, all teachers’’ and inserting 

4 ‘‘at least one teacher per classroom who is’’; 

5 (B) by striking ‘‘Early Head Start pro6 grams located in Early Head Start centers, 

7 have a minimum’’ and inserting ‘‘an Early 

8 Head Start program located in an Early Head 

9 Start center, has a minimum’’; 

10 (C) by striking ‘‘have been trained (or 

11 have’’ and inserting ‘‘has been trained (or has’’; 

12 and 

13 (D) by striking ‘‘and’’ at the end; 

14 (2) by redesignating paragraph (2) as para15 graph (3); 

16 (3) by inserting after paragraph (1) the fol17 lowing: 

18 ‘‘(2) ensure that— 

19 ‘‘(A) each additional teacher providing di20 rect services to children and families described 

21 in paragraph (1) is working towards earning a 

22 credential that is, at a minimum, a child devel23 opment associate credential and towards com24 pleting training (or equivalent coursework in 

25 early childhood development); and 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 7467 IH

1 ‘‘(B) during the period in which such a 

2 teacher is working towards earning that creden3 tial and completing that training or coursework, 

4 the Early Head Start agency employing the 

5 teacher shall provide a mentor to oversee the 

6 progress and guide the work of the teacher to7 wards earning that credential and completing 

8 that training or coursework; and’’; and 

9 (4) in paragraph (3), as so redesignated— 

10 (A) by striking ‘‘not later than September 

11 30, 2012, all such teachers’’ and inserting ‘‘at 

12 least one teacher per classroom providing direct 

13 services to children and families described in 

14 paragraph (1) has’’; 

15 (B) by striking ‘‘(or have’’ and inserting 

16 ‘‘(or has’’; and 

17 (C) by striking the period at the end and 

18 inserting ‘‘, and that each additional teacher 

19 providing direct services to such children and 

20 families is working towards completing that 

21 training or coursework.’’. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
Exhibit 32.1


               CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
                            AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


 In connection with the Quarterly Report of First Health Group Corp. (the
 "Company") on Form 10-Q for the period ended September 30, 2004, as filed
 with the Securities and Exchange Commission on the date hereof (the
 "Report"), I, Edward L. Wristen, Chief Executive Officer of the Company, do
 hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
 Section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1)  The Report fully complies with the requirements of Section 13(a)
 or 15(d) of the Securities Exchange Act of 1934; and

      (2)  The information contained in the Report fairly presents, in all
 material respects, the financial condition and results of operations of the
 Company.


 /s/ Edward L. Wristen

 Edward L. Wristen
 President and Chief Executive Officer
 November 5, 2004
BY: 

IN THE SUPREME COURT OF THE STATE OF NEVADA 

JOSEPH MILLS, AN INDIVIDUA; AND 

PEGGY MILLS, AN INDIVIDUAL, 

Appellants, 

vs. 

SUPERIOR TRAFFIC SERVICES 

CORP., 

Respondent. 

No., 84523 

FOR L 

OCT 2 2022 

aiita 11 A. BROM 

OF UPR ,M C 

EPUTY CA.EP.7-

ORDER DISMISSING APPEAL AS ABANDONED 

After the settlement judge reported that the parties had agreed 

to a settlement, this court entered an order directing appellants to file a 

stipulation or motion to dismiss this appeal or otherwise inform this court 

of the status of this appeal within 30 days. To date, appellants have not 

responded to our order or otherwise communicated with this court. 

Accordingly, cause appearing, we dismiss this appeal as abandoned. 

It is so ORDERED. 

CLERK OF THE SUPREME COURT 

ELIZABETH A. BROWN 

cc: Hon. Joseph Hardy, Jr., District Judge 

John Walter Boyer, Settlement Judge 

Clear Counsel Law Group 

Springel & Fink, LLP 

Lemons, Grundy & Eisenberg 

Eighth District Court Clerk 

SUPREME COURT 

OF 

NEVADA 

CLERK'S ORDER 

1.11- 1947
July 30, 2014 

Clean Power Plants/Carbon Pollution Emission Guidelines for Existing 

A 

)

I I 

~· I 

Stationary Sources and Standards for Modified and Reconstructed Stationary Sources: EGUs 

Atlanta, GA 

Registration/Sign-up Sheet 

Time Number Name 

9:15 1 ' Vt i \Cl<\ ~\(t.\'i'\ 

9:20 2 

I ' - ---*~ c~( t;~j Ckvrt9:25 3 

(Y!cnK U>lL5hll 0/ ~ 

9:30 4 

Lft Vi~ f(~cY-:; 

9:35 5 

~l~ \)~01\ 

9:40 6 

L..J.cuJ..f'e I") Po<Z.. 

9:45 7 

j~hn DuJYlM 

9:50 8 

C) ·.'15 joJY10 rnut.efl9:55 9 

VtGK \ -..) JrYl 

10:00 10 

611 CU11/1 c!}Y) p S 0Y\ 

10:05 11 

(lfhJt?~ L,\J bo cDd (1-f\ 

10:10 12 

' 

C__r~ br 1 /1\Jl. 
.. 

10:15 13 ,, -,;.,· 

~·~\- Cd.') ( Cy" 

10:20 14 

Gt VIc\ 1.-<Ll'Yl ~,rf 

10:25 15 

~t\ . &· J<. l'i-v\Clf) 

10:30 16 

Kc\rlc.Ulf..Y<.l:;. Gcf-5 ( i\_ 

10:40 17 

J)J~ kwYI m.Q )~·1 ck 

10:45 18 

(V~.tn s l tl n._ C\ ~(,, -~1 tN RcKl/() 

10:50 19 

r< <t.t1c·) , } t~ i r I 

10:55 20 

K.,nct~(\1- rY/(nftt 0 J\1 :Jf r f\ f\ c \JYli' 

11:00 21 

.j L \?tHL k, t~ cvf.. 

11:05 22 ~ ' L.oJ[ t__o 1 rr·L9- (r / t+cu lc ! 

11:10 23 

~ f\c\} l 2c\Y'I''} I 

11:15 24 

bill \) CY' J\i! (~ 

11:20 25 

Kcu~\.1/,{ l.U-t ll 

11:25 26 

\:\)cd~ +u~ r (!. t'·/[ u -. 

11:30 27 

v~~l'j 1r 1 l 

' &l11K bfc.-V\ 
• 

11:35 

11:40 

11:45 

11:50 

11:55 

LUNCH 12-1; reading opening 

statements 1:00-1:15 

1:15 

1:20 

28 

(f) ... :\kc:~{ n. kLH1lbtlt--

31 

32 

33 -

:t \ s*-~,~ cu~ll/5 34 

-G ~F' rnwAa 

1:25 

1:30 

1:35 

1:40 

1:45 

1:50 

1:55 

A 
' 

2:00 t.fi! 

4

bictR . (cj ft t. ,_... - ·un l ,.(V 

2:05 <.J0 43 

V\:1'Y\~fi \l>ll11D {' 

2:10 @ 44 

Dj 01.n C__D\eDr'"" 

2:15 tfY 45 

q __ \ (/Jt ~ge,-{-\.1 II\ l(:J vr:.,s 

2:20 @ 46 

-rn~'S ?:f..\J0( ' 1-

2:25 cif> 47 

0(iu (\L, s-oooy 

2:30 4LJ 48 <:!!;:/ 

0Jdl (_ Vlo&J._J h 

2:35 0J) 49 

t{)JQn S \.w.a ~ ~ 

2:40 CJ!j) 50 

'Wd.( NCl~~((() 2:45 @ 51 

I' IJ \ i+> QJ\ V---- 'eY (().(' 

2:50 c!PJ 52 

p..,\w+- (U)est:! 

2:55 ,r;v 53 

\ r\~ '\ 

1c,hc\ "\he:·rd--\ ~ 3:00 @) 54 

,..... \/'lu Q-c ·~ f~*"Yl 3:05 C-- 55 

\ Jv C·1.. ~ (!COCk\ 

3:10 C§P 56 J -J 

~:XXI (\( (\Cllf\ ' ' ..J 
A 

3:15 57 

3:20 58 

3:25 

3:30 

3:35 

3:40 62 

\\o-tt 

3:45 63 

3:50 

3:55 

4:00 

4:05 

4:10 

4:15 

4:20 

4:25 
4:50 

4:55 

5:00 

Dinner Break 5pm 

6:00 

6:05 

6:10 

6:15 

6:20 

6:25 

6:30 

6:35 

6:40 

6pm; 

76 J 

77 

78 

79 

80 

81 

82 

83 

84 

85 

86 
I • 

6:45 87 

6:50 88 

6:55 89 

7:00 90 

7:05 91 

7:10 92 

7:15 93 

7:20 94 

7:25 95 

7:30 96 

7:35 97 

7:40 98 

7:45 99 

7:50 100 

7:55 101 

------------------------------------
<PAGE>   1
                                                                    EXHIBIT 23.2

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS




      We consent to the incorporation by reference in the Registration Statement
(Form S-8) pertaining to the registration of 300,000 additional shares of common
stock issuable under the 1995 SeaMED Corporation Stock Option and Incentive Plan
of our report dated August 11, 1997, with respect to the financial statements
and schedule of SeaMED Corporation included in its Annual Report (Form 10-K) for
the year ended June 30, 1997.


Seattle, Washington                                   ERNST & YOUNG LLP
April 21, 1998
<PAGE>   1


                                                                      EXHIBIT 11

FRONTIER FINANCIAL CORPORATION AND SUBSIDIARIES   
COMPUTATION OF EARNINGS PER SHARE



<TABLE>
<CAPTION>
                                                For Three Months Ended March 31,

                                                   1999                1998
                                                -----------         -----------
<S>                                             <C>                 <C>        
Net Income                                      $ 5,994,092         $ 5,079,718
                                                ===========         ===========

Computation of average
shares outstanding

            Shares outstanding at
            beginning of year                     8,697,261           8,144,461

            Additional shares deemed
            outstanding because of
            stock dividends                              --             516,035

            Additional shares deemed
            outstanding because of
            stock splits                          8,758,499           8,667,480

            Shares issued during the
            year times average time
            outstanding during the year              56,423               6,984
                                                -----------         -----------

Average basic shares outstanding                 17,512,183          17,334,960
                                                -----------         -----------

Dilutive shares                                     109,893             195,901
                                                -----------         -----------

Average diluted shares outstanding               17,622,076          17,530,861
                                                -----------         -----------

Basic earnings per share                        $      0.34         $      0.29
                                                ===========         ===========


Diluted earnings per share                      $      0.34         $      0.29
                                                ===========         ===========

</TABLE>
# L_2019066DE.01000701.xml

| 7.3.2019 | DE | Amtsblatt der Europäischen Union | L 66/7 |
| --- | --- | --- | --- |

7.3.2019

DE

Amtsblatt der Europäischen Union

L 66/7

---

Berichtigung der Durchführungsverordnung (EU) 2018/1627 der Kommission vom 9. Oktober 2018 zur Änderung der Durchführungsverordnung (EU) Nr. 680/2014 im Hinblick auf die vorsichtige Bewertung für aufsichtliche Meldungen

(
  Amtsblatt der Europäischen Union L 281 vom 9. November 2018
  )

Seite 319, Anhang II zur Änderung des Anhangs II der Durchführungsverordnung (EU) Nr. 680/2014, Teil II Nummer 6.2.2 Tabelle „Zeilen“ Zeile 0040-0130 Absatz 4:

Anstatt:

„Die Aufschlüsselung in den Zeilen 0090 bis 0130 schließt die gemäß den Artikeln 12 und 13 der Delegierten Verordnung (EU) 2016/101 über die vorsichtige Bewertung berechneten AVAs ein,“

muss es heißen:

„Die Aufschlüsselung in den Zeilen 0090 bis 0130 schließt nicht die gemäß den Artikeln 12 und 13 der Delegierten Verordnung (EU) 2016/101 über die vorsichtige Bewertung berechneten AVAs ein,“.

---